Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations

Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):211-5. doi: 10.1161/01.ATV.0000149380.94984.f0. Epub 2004 Nov 4.

Abstract

Background: The effect of mutations on phenotype is often overestimated because of ascertainment bias. We determined the effect of background population on cholesterol phenotype associated with specific mutations in the low-density lipoprotein (LDL) receptor and the relative importance of background population and type of mutation (LDL receptor [LDLR] or APOB R3500Q) for cholesterol phenotype.

Methods and results: We studied 9255 individuals from the general population, 948 patients with ischemic heart disease (IHD), and 63 patients with clinical familial hypercholesterolemia (FH) for 3 common LDL receptor mutations. Average increase in cholesterol in LDL receptor heterozygotes identified in the general population or among patients with IHD or FH compared with noncarriers was 2.9 mmol/L, 4.1 mmol/L, and 4.9 mmol/L, respectively (P=0.02). Background population and type of mutation determined cholesterol phenotype; average increase in LDL cholesterol from carriers in the general population to carriers with clinical FH was 1.6 mmol/L (P=0.03). The average increase for carriers of LDLR mutations compared with carriers of APOB R3500Q was 1.2 mmol/L (P=0.05).

Conclusions: The phenotype associated with a given mutation should not be determined in patients, but rather in unselected individuals in the general population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amino Acid Substitution / genetics
  • Apolipoproteins B / genetics
  • Arginine / genetics
  • Bias
  • Cholesterol / blood
  • Cholesterol / genetics
  • Female
  • Genetic Carrier Screening / methods*
  • Genetics, Population / methods*
  • Glutamine / genetics
  • Humans
  • Hyperlipoproteinemia Type II / genetics
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Myocardial Ischemia / genetics
  • Phenotype
  • Receptors, LDL / genetics*

Substances

  • Apolipoproteins B
  • Receptors, LDL
  • Glutamine
  • Arginine
  • Cholesterol